Skip to main
BTSG

BTSG Stock Forecast & Price Target

BTSG Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 46%
Buy 54%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

BrightSpring Health is a healthcare company with a strong track record and a focus on delivering essential services to complex patients through their pharmacy solutions and provider services segments. They have seen growth in EBITDA margin and are embracing technology while being disciplined in their use of shareholder capital. Challenges in recruiting healthcare professionals and changes in Medicare and Medicaid rates may pose some risks, but BrightSpring Health is well-positioned for long-term growth with a confident outlook for the future.

Bears say

BrightSpring Health is a company with strong potential, given its specialized and in-demand healthcare services for senior and specialty patients. However, potential challenges in regulatory and affordability issues, as well as performance targets, may affect the success of its plans for organic growth and acquisitions. Additionally, while the company has succeeded in the Medicare and commercial sectors, challenges in the Medicaid sector and the potential gap between cost trend and rates could affect profitability in the future.

BTSG has been analyzed by 13 analysts, with a consensus rating of Buy. 46% of analysts recommend a Strong Buy, 54% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of BrightSpring Health Services Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About BrightSpring Health Services Inc (BTSG) Forecast

Analysts have given BTSG a Buy based on their latest research and market trends.

According to 13 analysts, BTSG has a Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $76, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $76, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

BrightSpring Health Services Inc (BTSG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.